Deputy Director – Integrated Development, Global Health, Bill & Melinda Gates Foundation
Raj Long is a senior executive with over 20 years of experience in the pharmaceutical industry. She brings a wide range of expertise in regulatory strategy and executive management experience having worked with the EMA, US FDA, CFDA and other Emerging Markets regulatory authorities.
She is currently a Deputy Director at the Bill & Melinda Gates Foundation (BMGF). Previously, she was the Global Head of Regulatory GEHC-MDx in the UK responsible for the regulatory organization and regulatory access globally in Americas, EMEA and Asia. Prior to joining GEHC, she held the position of Head of Regulatory International AGL in Novartis, Switzerland and Vice President – Regulatory International at Bristol-Myers Squibb, Princeton, USA. She was responsible for setting up strategic organizations in Asia, Latin America, Middle East and Africa with a focus on shaping drug development strategy.
In 2014 Raj became a member to the World Dementia Council (WDC) as a global regulatory expert. She was requested by the UK Department of Health to assess innovative development pathway for dementia. The report and recommendations Raj made have been supported and published by the UK government Minister of Health and Minister of Life Sciences in 2015. She was also selected to serve as an expert in the Innovative Medicines and Medtech Review Advisory
Group appointed by the Parliament Undersecretary for Health.
Prior to that Raj has held various positions in industry expert groups including ICH Expert and as EFPIA Lead. In 2016, Raj has been elected vice-chair of the World Dementia Council in 2016 and 2017. In addition, Raj also served as an expert at the invitation of the Dutch Government as part of the EU presidency to evaluate accelerated access and incentivized pricing models for the EU and in 2017 by the OECD to look at access in HICs and LICs on request by the G20 presidency.